Rachel Lamonica, DO
Obstetrics & Gynecology · New Britain, CTNPI 1114127735
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,435 of the $3,215 with a category attached, or 75.7%. Regeneron accounts for 75.7% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $2,537, more than ten times the $79 reported in 2019.
Across 32 payments — averaging $100.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$2K
- AbbVie$296
- Pfizer$107
- Gynesonics, Inc.$84
- Hologic Sales And Service, LLC$73
- Duchesnay USA Incorporated$41
- plus $179 from 8 others
What the payments were for
- Consulting fees$2,43576%
- Food & beverage$74523%
- Education$341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $2,435 |
| AbbVie | 11 | $296 |
| Pfizer | 6 | $107 |
| Gynesonics, Inc. | 1 | $84 |
| Hologic Sales And Service, LLC | 1 | $73 |
| Duchesnay USA Incorporated | 2 | $41 |
| AMAG Pharmaceuticals, Inc. | 2 | $34 |
| Applied Medical Resources Corporation | 1 | $31 |
| Intuitive Surgical | 1 | $29 |
| Exeltis, USA Inc. | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
How this compares
$3,215 in reported general payments places this provider in the 85th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $1,045 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New Britain
- Kyle BakerNew Britain$7K
- Gerard RoyNew Britain$6K
- Stephanie GarozzoNew Britain$5K
- Lisa RinaldiNew Britain$5K
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.